Endologix LLC, a privately held, global medical device company dedicated to providing disruptive therapies for the interventional treatment of vascular disease, is pleased to announce that Lucas Buchanan has been appointed to the Endologix Board of Directors.
Lucas Buchanan is currently the Chief Financial Officer and Chief Operating Officer at Silk Road Medical, Inc. He is widely recognized for his contributions to Silk Road Medical as the company introduced a new therapy for the treatment of carotid artery stenosis and changed the paradigm for patients with cerebrovascular disease. Mr. Buchanan played a pivotal role in financing the company and scaling its operations, including leading Silk Road’s initial public offering in 2019, and his role has continued to expand. Prior to Silk Road Medical, Mr. Buchanan’s background includes investing, business development, and operating roles at The Vertical Group, Impax Laboratories, Medtronic, and Ernst & Young. He holds an MBA in Health Care Management from The Wharton School at the University of Pennsylvania and a BA in Economics from Duke University.
Read More: https://endologix.com/news/endologix-announces-that-lucas-buchanan-joins-board-of-directors/
Via: Las Vegas Review-Journal
John Davis’ resume includes serving as a test engineer of radar systems on the Apollo modules that went to the moon. Click to listen.
VIa: Neuro News
A new study led by researchers from the University of Chicago Medicine (Chicago, USA) has revealed that nearly 75% of acute stroke patients wait more than two hours to be transferred to a comprehensive stroke center (CSC)—a treatment delay that creates an increased risk of long-term disability.
Sean Duffy has already raised hundreds of millions of dollars for his enterprise health company that is blending technology, behavior science, and medicine together.
A less invasive procedure to reduce the risk of stroke by clearing blockages of the carotid artery in the neck is being offered more widely as a result of recent approval by the Food & Drug Administration.
We are excited to offer our patients the Vivistim® System to magnify their potential to recover further.
One of the most frustrating things for our patients who had a stroke is the inability to perform activities of daily living because of the weakness of the upper limb.
Via; Hinge Health
We’re thrilled to announce that Hinge Health has been recognized in Employee Benefit News's 2022 Excellence in Benefits Awards! It's a reflection of Karen Stander, FACHE, Inessa Lurye, and the whole women’s pelvic health team's tireless work over the past year to help address the benefits gap that many women face when it comes to pelvic floor disorders. We’re proud to be a part of the conversation that advances the narrative around a condition that one in four women are silently suffering from: https://lnkd.in/dQHnYaFr
Dr. Peter Warnke and his team successfully completed the first vagus nerve stimulation implantation procedure in the Midwest
Via: Micro Transponder
This week neurosurgeon Dr. Peter Warnke and his team [at UChicago Medicine] successfully completed the first vagus nerve stimulation implantation procedure in the Midwest. Paired with rehabilitation this implant can help patients who have suffered from a stroke regain hand and arm movements.
Monteris Medical Announces First Patient Enrolled in REMASTer Clinical Study on NeuroBlate® System for Metastatic Brain Tumor Patients
Via: Monteris Medical
The randomized controlled multicenter study is the first-of-its kind to investigate LITT benefits in radiographically recurrent brain metastasis patients
Silk Road Medical Announces First Patient Enrolled in ROADSTER 3 Post Approval Study Evaluating TCAR® System in the Treatment of Standard Surgical Risk Patients
Via: Yahoo Finance